<DOC>
	<DOCNO>NCT00769886</DOCNO>
	<brief_summary>The purpose study establish safety efficacy ketotifen/naphazoline ophthalmic solution compare vehicle individual component alleviate sign symptom conjunctival allergen challenge ( CAC ) -induced allergic conjunctivitis .</brief_summary>
	<brief_title>Ketotifen/Naphazoline Ophthalmic Solution Conjunctival Allergen Challenge Model Allergic Conjunctivitis .</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ketotifen</mesh_term>
	<mesh_term>Naphazoline</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Positive history ocular allergy positive skin test reaction cat hair , cat dander , grass , ragweed , and/or tree within past 24 month . Calculated bestcorrected visual acuity 0.7 logMAR good eye measure use ETDRS chart . Positive bilateral conjunctival allergen challenge ( CAC ) reaction within 10 minute instillation last titration allergen visit 1 . Positive bilateral CAC reaction least 2 3 time point visit 2 . Known contraindication sensitivity study medication component . Any ocular condition , opinion investigator , could affect subject safety trial parameter . Use disallow medication period indicate prior study enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>